Welcome to LookChem.com Sign In|Join Free
  • or
(R)-1-[1-(2-cyanobenzyl)-5-(dimethylamino)-3-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yl]piperidine-3-tert-butyl carbamate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1314947-07-3

Post Buying Request

1314947-07-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1314947-07-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1314947-07-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,4,9,4 and 7 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1314947-07:
(9*1)+(8*3)+(7*1)+(6*4)+(5*9)+(4*4)+(3*7)+(2*0)+(1*7)=153
153 % 10 = 3
So 1314947-07-3 is a valid CAS Registry Number.

1314947-07-3Downstream Products

1314947-07-3Relevant academic research and scientific papers

FUSED PYRIDINE DERIVATIVES

-

Page/Page column 55-56, (2012/12/13)

Fused pyridine derivatives shown as the general formula (I), and their pharmaceutically acceptable salts, stereoisomers or solvates thereof are disclosed, which belong to the technical field of medicines. The R1, R2, R3, Q, X and Y substituents in formula (I) are defined as in the description. Also disclosed are the preparation methods, pharmaceutical compositions comprising the compounds and uses of the compounds in the manufacture of the medicine for the treatment and/or prevention of noninsulin-dependent diabetes, hyperglycemia, hyperlipidemia and insulin resistance.

FUSED PYRIDINE DERIVATIVES

-

Page/Page column 62-64, (2012/12/13)

Fused pyridine derivatives shown as the general formula (I), and their pharmaceutically acceptable salts, stereoisomers or solvates thereof are disclosed, which belong to the technical field of medicines. The R1, R2, R3, Q, X and Y substituents in formula (I) are defined as in the description. Also disclosed are the preparation methods, pharmaceutical compositions comprising the compounds and uses of the compounds in the manufacture of the medicine for the treatment and/or prevention of noninsulin-dependent diabetes, hyperglycemia, hyperlipidemia and insulin resistance.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1314947-07-3